| Obesity as a risk factor for dementia and Alzheimer’s disease: the role of leptin JA Flores-Cordero, A Pérez-Pérez, C Jiménez-Cortegana, G Alba, ... International journal of molecular sciences 23 (9), 5202, 2022 | 75 | 2022 |
| NK cells and solid tumors: therapeutic potential and persisting obstacles L Tong, C Jiménez-Cortegana, AHM Tay, S Wickström, L Galluzzi, ... Molecular cancer 21 (1), 206, 2022 | 58 | 2022 |
| Role of leptin in non-alcoholic fatty liver disease C Jiménez-Cortegana, A García-Galey, M Tami, P Del Pino, I Carmona, ... Biomedicines 9 (7), 762, 2021 | 55 | 2021 |
| Myeloid-derived suppressor cells and radiotherapy C Jiménez-Cortegana, C Galassi, V Klapp, DI Gabrilovich, L Galluzzi Cancer Immunology Research 10 (5), 545-557, 2022 | 41 | 2022 |
| Leptin, both bad and good actor in cancer C Jiménez-Cortegana, A López-Saavedra, F Sánchez-Jiménez, ... Biomolecules 11 (6), 913, 2021 | 39 | 2021 |
| Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from … C Jiménez-Cortegana, N Palazón-Carrión, AM Garcia-Sancho, ... Journal for immunotherapy of cancer 9 (6), 2021 | 27 | 2021 |
| Nutritional modulation of leptin expression and leptin action in obesity and obesity-associated complications S Montserrat-de la Paz, A Pérez-Pérez, T Vilariño-García, ... The Journal of Nutritional Biochemistry 89, 108561, 2021 | 26 | 2021 |
| Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer N Palazón-Carrión, C Jiménez-Cortegana, ML Sánchez-León, ... Scientific Reports 11 (1), 14426, 2021 | 20 | 2021 |
| Role of Leptin as a link between Asthma and Obesity: A systematic Review and Meta-Analysis H Sánchez-Ortega, C Jiménez-Cortegana, JP Novalbos-Ruiz, ... International Journal of Molecular Sciences 24 (1), 546, 2022 | 15 | 2022 |
| Nutrients and dietary approaches in patients with type 2 diabetes mellitus and cardiovascular disease: A narrative review C Jiménez-Cortegana, P Iglesias, J Ribalta, T Vilariño-García, ... Nutrients 13 (11), 4150, 2021 | 15 | 2021 |
| Increased blood monocytic myeloid derived suppressor cells but low regulatory T lymphocytes in patients with mild COVID-19 C Jiménez-Cortegana, J Liró, N Palazón-Carrión, E Salamanca, ... Viral immunology 34 (9), 639-645, 2021 | 14 | 2021 |
| Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy V Sánchez-Margalet, A Barco-Sánchez, T Vilariño-García, ... Translational Cancer Research 8 (1), 59, 2019 | 13 | 2019 |
| Low levels of granulocytic myeloid-derived suppressor cells may be a good marker of survival in the follow-up of patients with severe COVID-19 C Jiménez-Cortegana, F Sánchez-Jiménez, A Pérez-Pérez, N Álvarez, ... Frontiers in immunology 12, 801410, 2022 | 12 | 2022 |
| Possible role of leptin in atopic dermatitis: A literature review C Jiménez-Cortegana, G Ortiz-García, A Serrano, D Moreno-Ramírez, ... Biomolecules 11 (11), 1642, 2021 | 11 | 2021 |
| The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells ML Sánchez-León, C Jiménez-Cortegana, G Cabrera, EM Vermeulen, ... Frontiers in Immunology 13, 1050484, 2022 | 10 | 2022 |
| Tumor immune microenvironment in lymphoma: Focus on epigenetics DJ García-Domínguez, L Hontecillas-Prieto, N Palazón-Carrión, ... Cancers 14 (6), 1469, 2022 | 10 | 2022 |
| Expression of nutrient transporters in placentas affected by gestational diabetes: role of leptin P Guadix, I Corrales, T Vilariño-García, C Rodríguez-Chacón, ... Frontiers in Endocrinology 14, 1172831, 2023 | 8 | 2023 |
| Obesity and Risk for Lymphoma: Possible Role of Leptin C Jiménez-Cortegana, L Hontecillas-Prieto, DJ García-Domínguez, ... International Journal of Molecular Sciences 23 (24), 15530, 2022 | 8 | 2022 |
| Myeloid-derived suppressor cells and vaccination against pathogens E Prochetto, E Borgna, C Jimenez-Cortegana, V Sánchez-Margalet, ... Frontiers in Cellular and Infection Microbiology 12, 1003781, 2022 | 7 | 2022 |
| Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study L de la Cruz-Merino, M Gion, J Cruz, JL Alonso-Romero, V Quiroga, ... BMC cancer 22 (1), 1258, 2022 | 6 | 2022 |
